Variable name | HIV negative (n = 334) (%) | HIV positive (n = 26) (%) | OR (95% CI) | p value |
---|---|---|---|---|
Respondent variables | ||||
Years of injection drug use (quartiles) | ||||
0–6 | 100 (29.9) | 2 (7.7) | 1.0 |  |
7–13 | 83 (24.9) | 11 (42.3) | 6.6 (1.4–30.7) | 0.016 |
14–21 | 71 (21.3) | 7 (26.9) | 4.9 (0.9–24.4) | 0.051 |
22–39 | 80 (24.0) | 6 (23.1) | 3.75 (0.7–19.0) | 0.111 |
Gender | Â | Â | Â | Â |
Male | 193 (57.8) | 13 (50.0) | 1.0 | Â |
Female | 141 (42.2) | 13 (50.0) | 1.4 (0.6–3.0) | 0.442 |
Education level | Â | Â | Â | Â |
< grade 12 | 234 (70.1) | 19 (73.1) | 1.0 | Â |
> grade 12 | 100 (29.9) | 7 (26.9) | 0.9 (0.4–2.1) | 0.744 |
Ethnicity | Â | Â | Â | Â |
Caucasian | 125 (37.4) | 3 (11.5) | 1.0 | Â |
Aboriginal | 209 (62.6) | 23 (88.5) | 4.6 (1.4–15.6) | 0.004 |
Mobility | Â | Â | Â | Â |
In Winnipeg > 1 year | 244 (73.1) | 18 (69.2) | 1.0 | Â |
Moved to Winnipeg in past year | 90 (27.0) | 8 (30.8) | 1.2 (0.5–2.9) | 0.677 |
Deals drugs | Â | Â | Â | Â |
No | 175 (52.4) | 15 (57.7) | 1.0 | Â |
Yes | 159 (47.6) | 11 (42.3) | 0.8 (0.4–1.8) | 0.601 |
Cocaine use | Â | Â | Â | Â |
No | 122 (36.5) | 6 (23.1) | 1.0 | Â |
Yes | 212 (63.5) | 20 (76.9) | 1.9 (0.7–4.9) | 0.154 |
Talwin/ritalin use | ||||
No | 228 (68.3) | 16 (61.5) | 1.0 | Â |
Yes | 106 (31.7) | 10 (38.5) | 1.3 (0.6–3.1) | 0.486 |
Morphine use | Â | Â | Â | Â |
No | 209 (62.6) | 21 (80.8) | 1.0 | Â |
Yes | 125 (37.4) | 5 (19.2) | 0.4 (0.1–1.1) | 0.051 |
Heroin use | Â | Â | Â | Â |
No | 299 (89.5) | 26 (100) | Â | Â |
Yes | 35 (10.5) | 0 (0.00) | Not defined | Â |
Injects daily | Â | Â | Â | Â |
No | 52 (15.6) | 5 (19.2) | 1.0 | Â |
Yes | 282 (84.4) | 21 (80.8) | 0.8 (0.3–2.1) | 0.631 |
Injected at a hotel | ||||
No | 198 (59.3) | 16 (61.5) | 1.0 | Â |
Yes | 136 (40.7) | 10 (38.5) | 0.9 (0.4–2.1) | 0.821 |
injected at a shooting gallery | ||||
No | 287 (85.9) | 17 (65.4) | 1.0 | Â |
Yes | 47 (14.1) | 9 (34.6) | 3.2 (1.4–7.7) | 0.012 |
Ever used someone else's syringe | ||||
No | 136 (40.7) | 2 (7.7) | 1.0 | Â |
Yes | 198 (59.3) | 24 (92.3) | 8.2 (1.9–35.5) | <0.001 |
Injected someone else as a service | ||||
No | 256 (76.7) | 13 (50.0) | 1.0 | Â |
Yes | 78 (23.3) | 13 (50.0) | 3.3 (1.5–7.4) | 0.005 |
Obtains syringes from friends | ||||
No | 106 (31.7) | 13 (50.0) | 1.0 | Â |
Yes | 228 (68.3) | 13 (50.0) | 0.5 (0.2–1.0) | 0.063 |
Obtains syringes from questionable sources | ||||
No | 257 (77.0) | 19 (73.1) | 1.0 | Â |
Yes | 77 (23.1) | 7 (26.9) | 1.2 (0.5–3.0) | 0.658 |
Opposite-sex regular partners | ||||
No | 105 (31.4) | 8 (30.8) | 1.0 | Â |
Yes | 229 (68.6) | 18 (69.2) | 1.0 (0.4–2.4) | 0.944 |
Opposite-sex casual partners | ||||
No | 208 (62.3) | 18 (69.2) | 1.0 | Â |
Yes | 126 (37.7) | 8 (30.8) | 0.7 (0.3–1.7) | 0.474 |
Opposite-sex client partners | ||||
No | 290 (86.8) | 19 (73.1) | 1.0 | Â |
Yes | 44 (37.7) | 7 (26.9) | 2.4 (1.0–6.1) | 0.076 |
Regular same-sex partners | ||||
No | 326 (97.6) | 24 (92.3) | 1.0 | Â |
Yes | 8 (2.4) | 2 (7.7) | 3.4 (0.7–16.9) | 0.183 |
Casual same-sex partners | ||||
No | 320 (95.8) | 25 (96.2) | 1.0 | Â |
Yes | 14 (4.2) | 1 (3.9) | 0.9 (0.1–7.2) | 0.932 |
Client same-sex partners | ||||
No | 329 (98.5) | 23 (88.5) | 1.0 | Â |
Yes | 5 (1.5) | 3 (11.5) | 8.6 (1.9–38.2) | 0.013 |
Egocentric network variables (maximum number of network members = 20) | ||||
Total number of IDU in network | ||||
Median (IQR) | 3 (2,5) | 2 (0,5) | 0.9 (0.8–1.1) | 0.241 |
Total number of IDU family members in network | ||||
Median (IQR) | 0 (0,1) | 0 (0,2) | 1.2 (0.9–1.6) | 0.260 |
Spouse IDU in network | ||||
No | 215 (64.4)) | 17 (65.4) | 1.0 | Â |
Yes | 119 (35.6) | 9 (34.6) | 1.0 (0.4–2.2) | 0.917 |
IDU risk network variables (maximum number of IDU = 5) | ||||
Number of IDU respondent sees daily | ||||
None | 107 (32.0) | 12 (46.2) | 1.0 | Â |
1 | 112 (33.5) | 6 (23.1) | 0.5 (0.2–1.3) | 0.154 |
2 | 58 (17.4) | 5 (19.2) | 0.8 (0.3–2.3) | 0.637 |
3–5 | 57 (17.1) | 3 (11.5) | 0.5 (0.1–1.7) | 0.256 |
Number of IDU in network who inject daily | ||||
None | 191 (57.2) | 17 (65.4) | 1.0 | Â |
1 | 63 (18.9) | 2 (7.7) | 0.4 (0.1–1.6) | 0.176 |
2 | 45 (13.5) | 4 (15.4) | 1.0 (0.3–3.1) | 0.998 |
3–5 | 35 (10.5) | 3 (11.5) | 1.0 (0.3–3.5) | 0.954 |
Number of IDU in network who have been IDU for >5 years | ||||
0 | 159 (47.6) | 14 (53.9) | 1.0 | Â |
1 | 65 (19.5) | 3 (11.5) | 0.5 (0.1–1.9) | 0.323 |
2 | 52 (15.6) | 4 (15.4) | 0.9 (0.3–2.8) | 0.819 |
3–5 | 58 (17.4) | 5 (19.2) | 1.0 (0.3–2.8) | 0.969 |
Number of IDU in network who have injected at a hotel | ||||
0 | 207 (62.0) | 20 (76.9) | 1.0 | Â |
1 | 64 (19.2) | 2 (7.7) | 0.3 (0.1–1.4) | 0.135 |
2–5 | 63 (18.9) | 4 (15.4) | 0.7 (0.2–2.0) | 0.458 |
Number of IDU in network who have injected at a shooting gallery | ||||
0 | 254 (76.1) | 20 (76.9) | 1.0 | Â |
1 | 43 (12.9) | 2 (7.7) | 0.6 (0.1–2.6) | 0.488 |
2–5 | 37 (11.1) | 4 (15.4) | 1.4 (0.4–4.2) | 0.582 |
Number of IDU in network with whom respondent has pooled money | ||||
0 | 94 (28.1) | 12 (46.2) | 1.0 | Â |
1 | 91 (27.3) | 4 (15.4) | 0.3 (0.1–1.1) | 0.074 |
2–3 | 90 (27.0) | 6 (23.1) | 0.5 (0.2–1.5) | 0.213 |
4–5 | 59 (17.7) | 4 (15.4) | 0.5 (0.2–1.7) | 0.292 |
Number of IDU in network who have used a syringe before the respondent used it | ||||
0 | 255 (76.4) | 20 (76.9) | 1.0 | Â |
1 | 56 (16.8) | 4 (15.4) | 0.9 (0.3–2.8) | 0.869 |
2–5 | 23 (6.9) | 2 (7.7) | 1.1 (0.2–5.0) | 0.894 |
Number of IDU in network who have used other drug paraphernalia before respondent has used it. | ||||
0 | 201 (60.2) | 17 (65.4) | 1.0 | Â |
1 | 59 (17.7) | 3 (11.5) | 0.6 (0.2–2.1) | 0.429 |
2–5 | 74 (22.2) | 6 (23.1) | 1.0 (0.4–2.5) | 0.932 |
Number of IDU in network who have initiated respondent to injection drug use | ||||
0 | 242 (72.5) | 21 (80.8) | 1.0 | Â |
1 | 77 (23.1) | 5 (19.2) | 0.7 (0.3–2.1) | 0.563 |
2–5 | 15 (4.5) | 0 (0.0) | Not defined |  |
Number of IDU in network who have shown respondent how to inject drugs | ||||
0 | 229 (68.6) | 19 (73.1) | 1.0 | Â |
1 | 75 (22.5) | 6 (23.1) | 1.0 (0.4–2.5) | 0.940 |
2–5 | 30 (9.0) | 1 (3.9) | 0.4 (0.1–3.1) | 0.382 |
Number of IDU in network who have injected respondent with drugs | ||||
0 | 161 (48.2) | 12 (46.2) | 1.0 | Â |
1 | 95 (28.4) | 5 (19.2) | 0.7 (0.2–2.1) | 0.525 |
2–5 | 78 (23.4) | 9 (34.6) | 1.5 (0.6–3.8) | 0.344 |
Number of IDU in network who have used talwin/ritalin | ||||
0 | 239 (71.6) | 17 (65.4) | 1.0 | Â |
1–3 | 54 (16.2) | 4 (15.4) | 1.0 (0.3–3.2) | 0.944 |
4–5 | 41 (12.3) | 5 (19.2) | 1.7 (0.6–4.9) | 0.315 |
Number of IDU in network who have used cocaine | ||||
0 | 210 (62.9) | 18 (69.2) | 1.0 | Â |
1 | 55 (16.5) | 3 (11.5) | 0.6 (0.2–2.2) | 0.481 |
2–3 | 44 (13.2) | 4 (15.4) | 1.1 (0.3–3.3) | 0.919 |
4–5 | 25 (7.5) | 1 (3.9) | 0.5 (0.1–3.6) | 0.467 |
Number of IDU in network who have used morphine | ||||
0 | 255 (76.4) | 21 (80.8) | 1.0 | Â |
1 | 46 (13.8) | 4 (15.4) | 1.1 (0.3–3.2) | 0.924 |
2–5 | 33 (9.9) | 1 (3.9) | 0.4 (0.0–2.8) | 0.336 |